Omicron vaccine

Moderna announces positive results for Omicron vaccine

The 'bivalent' vaccine was tested in a trial for 850 adults, who had all received their first three doses of Moderna's original Spikevax vaccine. 

published on : 8th June 2022

Covaxin booster effective in neutralising Omicron, says Bharat Biotech

Sera samples from individuals who received a booster of Covaxin were observed to be effective in neutralizing Omicron and Delta variants, the firm said in a statement.

published on : 12th January 2022

Expert panel ponders upon restructuring of COVID vaccines against Omicron

NK Arora, head of COVID Working Group of the NTAGI, told that daily deliberations are on whether the existing vaccines in India can be specifically tailored against Omicron.

published on : 9th January 2022

Computer model predicts Omicron may evolve to increase transmission, immune escape

The study found that Omicron's spike proteins bind better than the Delta variant to the human ACE2 receptor.

published on : 6th January 2022

Johnson & Johnson Covid booster highly effective against severe Omicron: Study

Antibody levels rose steadily after two Pfizer shots and a J&J shot, and were at higher levels after four weeks.

published on : 31st December 2021

60 per cent of India's adult population fully vaccinated: Health minister

Around 89 per cent of India's adults have been administered the first dose, according to health ministry officials.

published on : 23rd December 2021

Omicron can escape vaccine immunity: South African Medical Association Chair

While the intensity of symptoms with Omicron is less in those who are vaccinated, Dr. Coetzee said she observed this vaccine immunity-escape capability of Omicron from patient data.

published on : 11th December 2021

Top WHO official says existing vaccines failing against Omicron 'highly unlikely'

WHO emergencies director Michael Ryan said there was no sign that Omicron could fully sidestep protections provided by existing Covid vaccines.

published on : 8th December 2021

'Doesn't seem like that severe': Anthony Fauci on growing Omicron threat

Medical experts have in recent days underscored that the South African population skews young and that more severe cases could emerge in the coming weeks.

published on : 6th December 2021

Delta still dominates say experts urging third jab 

Pfizer, Johnson & Johnson and Moderna each say they have begun work on a new version of their vaccine specifically targeting Omicron -- in case existing jabs don't work against it.

published on : 4th December 2021